RLYB
Income statement / Annual
Last year (2025), Rallybio Corp's total revenue was $858.00 K,
an increase of 34.91% from the previous year.
In 2025, Rallybio Corp's net income was -$8.98 M.
See Rallybio Corp,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$858.00 K |
$636.00 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$92.00 K
|
$0.00
|
$150.00 K
|
$167.00 K
|
$109.00 K
|
$62.03 K
|
$26.34 K
|
| Gross Profit |
$766.00 K
|
$636.00 K
|
-$150.00 K
|
-$167.00 K
|
-$109.00 K
|
-$62.03 K
|
-$26.34 K
|
| Gross Profit Ratio |
0.89
|
1
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$19.60 M
|
$41.51 M
|
$53.54 M
|
$40.69 M
|
$26.91 M
|
$17.63 M
|
$11.37 M
|
| General & Administrative Expenses |
$14.33 M
|
$19.63 M
|
$25.39 M
|
$27.20 M
|
$18.74 M
|
$7.67 M
|
$6.28 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$14.33 M
|
$19.63 M
|
$25.39 M
|
$27.20 M
|
$18.74 M
|
$7.67 M
|
$6.28 M
|
| Other Expenses |
-$5.09 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$28.83 M
|
$61.13 M
|
$78.93 M
|
$67.88 M
|
$45.65 M
|
$25.30 M
|
$17.64 M
|
| Cost And Expenses |
$28.92 M
|
$61.13 M
|
$78.93 M
|
$67.88 M
|
$45.65 M
|
$25.30 M
|
$17.64 M
|
| Interest Income |
$2.19 M
|
$4.22 M
|
$6.15 M
|
$1.96 M
|
$54.00 K
|
$171.00 K
|
$197.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$10.00 K
|
$49.00 K
|
$39.00 K
|
| Depreciation & Amortization |
$92.00 K
|
$131.00 K
|
$150.00 K
|
$167.00 K
|
$109.00 K
|
$62.00 K
|
$26.34 K
|
| EBITDA |
-$27.97 M |
-$60.37 M |
-$78.78 M |
-$67.72 M |
-$45.39 M |
-$25.24 M |
-$17.39 M |
| EBITDA Ratio |
-32.6
|
-94.91
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-32.71
|
-95.12
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$19.09 M
|
$2.72 M
|
$4.37 M
|
$1.23 M
|
-$1.37 M
|
-$1.16 M
|
$79.00 K
|
| Income Before Tax |
-$8.98 M
|
-$57.78 M
|
-$74.56 M
|
-$67.73 M
|
-$47.01 M
|
-$26.46 M
|
-$17.46 M
|
| Income Before Tax Ratio |
-10.46
|
-90.84
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
-$1.08 M
|
$0.00
|
-$15.00 K
|
$0.00
|
| Net Income |
-$8.98 M
|
-$57.78 M
|
-$74.56 M
|
-$66.65 M
|
-$47.01 M
|
-$26.45 M
|
-$17.63 M
|
| Net Income Ratio |
-10.46
|
-90.84
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.59 |
-10.64 |
-14.72 |
-16.72 |
-11.68 |
-9.52 |
-4.4 |
| EPS Diluted |
-1.59 |
-10.64 |
-14.72 |
-16.72 |
-11.68 |
-9.52 |
-6.32 |
| Weighted Average Shares Out |
$5.63 M
|
$5.44 M
|
$5.06 M
|
$3.98 M
|
$4.02 M
|
$2.78 M
|
$2.78 M
|
| Weighted Average Shares Out Diluted |
$5.63 M
|
$5.44 M
|
$5.06 M
|
$3.98 M
|
$4.02 M
|
$2.78 M
|
$2.78 M
|
| Link |
|
|
|
|
|
|
|
